Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x100px

Organisation › Details

Lonza Pharma Biotech & Nutrition (LPBN) (segment)

	Start	2019-03-01 restructured
	Group	Lonza (Group)
	Predecessor	Lonza Pharma & Biotech (division)
	Industry	contract manufacturing (biologicals)
	Industry 2	contract manufacturing (drugs)
	Person	Stoffel, Stefan (Lonza 201903– COO of Lonza Pharma Biotech & Nutrition segment joined 1991)

	Region	Basel BS
	Country	Switzerland
	City	n. a.
		Address record changed: 2019-02-28

Basic data	Employees	n. a.


		Record changed: 2025-03-16

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x200px

More documents for Lonza (Group)

[1] Lonza Group AG. (4/2/24). "Press Release: Wolfgang Wienand, Currently CEO of Swiss CDMO Siegfried Holding AG, Will Become Chief Executive Officer of Lonza in the Summer of 2024". Basel....
[2] Lonza Group AG. (3/20/24). "Press Release: Lonza Signs Agreement to Acquire Large-scale Biologics Site in Vacaville (US) from Roche". Basel....
[3] Cellbox Solutions GmbH. (11/1/23). "Press Release: Dr. Hartmut Tintrup Joins Cellbox Solutions GmbH as new CEO". Cologne....
[4] Lonza Group AG. (9/18/23). "Press Release: Board Announcement. CEO Pierre-Alain Ruffieux to Leave Lonza – Albert M. Baehny to Step in as CEO ad interim". Basel....
[5] PolyPeptide Group AG. (8/15/23). "Press Release: Transformational Progress Taking Shape, Profitability Impacted by Rapid Expansion – Appointment of Marc Augustin as New CFO". Baar....
[6] Lonza Group Ltd.. (6/1/23). "Press Release: Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering". Basel & Amsterdam....
[7] Synaffix B.V.. (1/5/23). "Press Release: Synaffix Enters License Agreement with Amgen to Build Next Generation ADCs". Amsterdam....
[8] Synaffix B.V.. (1/4/23). "Press Release: Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program". Amsterdam, San Francisco, CA, et al.....
[9] Emergence Therapeutics AG. (9/6/22). "Press Release: Emergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Deal". Amsterdam & Duisburg....
[10] Rentschler Biopharma SE. (8/18/22). "Press Release: Rentschler Biopharma Appoints Mark Caswell as Vice President, Site Head for US Facility". Laupheim & Milford, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]